Skip to main content

New Investigator Cancer Trials Practicum

New Investigator Cancer Trials Practicum
A training program in cancer clinical trial conduct

The purpose of the CCTG New Investigator Cancer Trials Practicum is to deliver a training program that includes practical trial experience at cancer sites throughout Canada over a one-year period. This unique program and the first of its kind in Canada, enables the best and brightest new Canadian oncology researchers to acquire training and experience in cancer clinical trial conduct. At the culmination of training, researchers will receive the Cancer Trials Investigator Certificate as proof of their expertise.

The certificate program will contain two components:

  1. A 12-month curriculum including observer-ships at CCTG disease site committee meetings and other key CCTG scientific committees; opportunity to receive teaching and mentorship through the CCTG Operations and Statistic Centre on practical aspects of clinical trial conduct not readily available at other courses;
  2. Direct clinical trial mentorship at the site through involvement in a CCTG clinical trial.

Applications are now closed

The investigator will have the following opportunities over the 12-month practicum:

The 12-month certificate program will commence at the New Investigator meeting at the CCTG annual meeting in the spring of 2026. To receive their certificates, new investigators must complete all the assigned components and receive satisfactory feedback from mentors. 

  • Attendance at the annual spring meeting and fall Investigational New Drugs meeting in Toronto
  • Participation in an orientation meeting at the Operations and Statistical Centre in Kingston
  • Participation in a site monitoring visit (average of two nights accommodation and transportation)
  • Participation in trial and scientific committee conference calls and virtual meetings
  • Participation in at least one meeting of the CCTG Data Safety and Monitoring Committee and CCTG Clinical Trials Committee

Congratulations to the 2026-2027 participants.

2026-2027 New investigator Practicum

 

 

 

 
 

2025-2026 Practicum

2024-25 CCTG Practicum

PRACTICUM PARTICIPANTS

2022

2020-22

Thai-HoaTran
Thai-HoaTran

Dr. Tran is Pediatric Hematologist-Oncologist, Leukemia Program, at CHU Sainte-Justine and Clinical Adjunct Professor, Department of Pediatrics, Université de Montréal.

Jacques Raphael
Jacques Raphael

Dr. Raphael is a Medical Oncologist at London Regional Cancer Program. Assistant Professor of Oncology, Schulich School of Medicine & Dentistry, Western University. His research interests include breast and Lung Cancer particularly in early phase drug trials and biomarker studies.

Ayesha Bashir
Ayesha Bashir

Dr. Bashir is an Oncologist with Allan Blair Cancer Centre in Regina and Assistant Professor of Medical Oncology at the University of Saskatchewan.

Ali Hosni Abdalaty
Ali Hosni Abdalaty

Dr. Hosni Abdalaty is an Assistant Professor at the University of Toronto and Radiation Oncologist with Princess Margaret Cancer Centre and the Radiation Medicine Program at UHN.

Aly Khan Lalani
Aly Khan Lalani

Dr. Lalani is an Assistant Professor at McMaster University and a Medical Oncologist at the Juravinski Cancer Centre.

Terry Ng
Terry Ng

Dr. Terry Ng is an Assistant Professor at the University of Ottawa and a Clinician-Investigator in the Department of Medicine. Dr. Ng’s research interests have focused on treatment-related adverse events.


The first practicum 2018-2019